Patents Assigned to ITF Research Pharma, S.L.U.
  • SOFT GELATIN CAPSULES
    Publication number: 20230263736
    Abstract: The present invention relates to soft gelatin capsules, to the use of the soft gelatin capsule as a food supplement, dietary supplement and health supplement, to a process for preparing the soft gelatin capsule, to the soft gelatin capsule for use in medicine and to the soft gelatin capsule for use in the treatment and/or prevention of a disease or pathology.
    Type: Application
    Filed: June 24, 2021
    Publication date: August 24, 2023
    Applicant: ITF RESEARCH PHARMA, S.L.U
    Inventors: Jaime MOSCOSO DEL PRADO, Katia URSO, Elena PÉREZ HERNANDO
  • Progesterone intravaginal devices
    Patent number: 11278491
    Abstract: The invention relates to intravaginal devices, in particular rings, comprising progesterone in a particular polymorphic purity, methods for making such devices and therapeutic uses of said devices. In particular, the intravaginal devices comprise a high amount of progesterone polymorph I and are useful in the treatment of infertility in a female subject.
    Type: Grant
    Filed: March 21, 2019
    Date of Patent: March 22, 2022
    Assignee: ITF Research Pharma, S.L.U.
    Inventors: Concepción Nieto Magro, Elena Pérez Hernando, Jaime Moscoso Del Prado, Javier Suárez Almarza
  • PROGESTERONE INTRAVAGINAL DEVICES
    Publication number: 20210030666
    Abstract: The invention relates to intravaginal devices, in particular rings, comprising progesterone in a particular polymorphic purity, methods for making such devices and therapeutic uses of said devices. In particular, the intravaginal devices comprise a high amount of progesterone polymorph I and are useful in the treatment of infertility in a female subject.
    Type: Application
    Filed: March 21, 2019
    Publication date: February 4, 2021
    Applicant: ITF RESEARCH PHARMA, S.L.U.
    Inventors: Concepción NIETO MAGRO, Elena PÉREZ HERNANDO, Jaime MOSCOSO DEL PRADO, Javier SUÁREZ ALMARZA
  • Use of vaginal insulin sensitizing agents
    Patent number: 9339458
    Abstract: A method for the treatment and/or prevention of hyperandrogenism and/or polycystic ovary syndrome and/or related disorders comprising the vaginal administration of at least one insulin-sensitizing agent.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: May 17, 2016
    Assignee: ITF RESEARCH PHARMA, S.L.U.
    Inventors: Jaime Moscoso Del Prado, Beatriz Banfi Tosi
  • Treatment of vaginal atrophy in women with tumor pathology risk
    Patent number: 9114143
    Abstract: The present invention relates to the use of estriol in the preparation of a pharmaceutical formulation for vaginal administration with the capacity to self-limit the absorption of estriol, for the prevention and/or the treatment of urogenital atrophy in women, said women having a high probability of developing an estrogen-dependent tumor or suffering or having suffered from an estrogen-dependent tumor.
    Type: Grant
    Filed: August 7, 2009
    Date of Patent: August 25, 2015
    Assignee: ITF RESEARCH PHARMA, S.L.U.
    Inventors: Álvaro Acebrón Fernández, Dolores Blanco Lousame, Jaime Moscoso Del Prado, Concepción Nieto Magro
  • Treatment of vaginal atrophy in women with cardiovascular pathology risk
    Patent number: 8835414
    Abstract: The present invention relates to the use of estriol in the preparation of a pharmaceutical formulation for vaginal administration with the capacity to self-limit the absorption of estriol, for the prevention and/or the treatment of urogenital atrophy in women said women having a high probability of suffering from a cardiovascular pathology or suffering or having suffered from a cardiovascular pathology.
    Type: Grant
    Filed: August 7, 2009
    Date of Patent: September 16, 2014
    Assignee: ITF Research Pharma S.L.U.
    Inventors: Álvaro Acebrón Fernández, Dolores Blanco Lousame, Jaime Moscoso Del Prado, Concepción Nieto Magro
  • Semi-solid mucoadhesive formulations
    Patent number: 8663688
    Abstract: Semisolid mucoadhesive formulations for vaginal application, with improved technical and organoleptic characteristics, which contain at least two bioadhesive gelling polymers and an active ingredient, useful in the prevention and/or treatment of various pathologies and disorders in human beings or animals.
    Type: Grant
    Filed: July 16, 2004
    Date of Patent: March 4, 2014
    Assignee: ITF Research Pharma, S.L.U.
    Inventors: Álvaro Acebrón Fernández, Ana Campuzano Garcia, Rosa Maria Hernández Martin, Manuela Igatúa Olaechea, José Luis Pedraz Muñoz, Alicia Rodriguez Gascón